Business Development
What are we looking for?
Aenean sit amet pulvinar est, eu tempor felis. Sed eget augue id enim venenatis bibendum. Duis commodo suscipit tristique. Pellentesque et blandit turpis, sed rutrum lacus.
Donec ac felis eros. Aenean interdum lorem a dui pellentesque fringilla.
Integer faucibus adipiscing egestas. Vivamus vestibulum ullamcorper porta.
Vivamus porta diam diam, in commodo mi mattis eget:
- Vivamus elementum
- Sed dictum tortor sit amet
Lorum ipsum heading
Nulla vitae nisi lectus. Integer eget molestie massa, vel commodo urna. Nulla iaculis neque in sem porttitor, a fringilla nibh interdum. Donec velit sem, convallis non erat in, sodales laoreet dolor. Sed iaculis accumsan diam, sit amet tristique turpis scelerisque non.
Praesent ante turpis, porttitor eu malesuada vel, rutrum non neque. Nam congue nunc sit amet suscipit fermentum. Etiam vestibulum magna a eleifend ultricies.
Praesent ante turpis, porttitor eu malesuada vel, rutrum non neque. Nam congue nunc sit amet suscipit fermentum. Etiam vestibulum magna a eleifend ultricies.
Who to contact
Preclinical Research Programs
The Director of Business Development for the Ferring Research Institute is responsible for review of peptide and protein based Preclinical Research Programs
Adrienne Day
Director, Business Development Research
Phone: +1 858 657 1511 (USA)
Email: adrienne.day@ferring.com
Early Stage Clinical Compounds and Drug Delivery Systems
Ferring’s Senior Vice President, Global Project and Portfolio Management leads the evaluation of R&D opportunities in pre-phase IIB development and consults with other relevant Ferring divisions. In addition, he leads the out-licensing process of Ferring’s early stage compounds.
Alan S. Harris
Senior Vice President, Global Project and Portfolio Management
Phone: +41 58 301 00 00 (Switzerland)
Email: alan.harris@ferring.com
Tony Mason
Director, Global Projects Management
Phone +41 58 301 00 00 (Switzerland)
Email: tony.mason@ferring.com
Late Stage and Merger & Acquisitions
Ferring’s Business Development team focuses on late stage compounds that are ready to go to phase IIb as well as on product and company acquisitions.
Please contact Global Business Development according to the following therapeutic areas or regions:
USA and Canada - Bipin Dalmia
Vice President, US Business Development
Phone +1 973 796 1600 (US)
Email: bipin.dalmia@ferring.com
Reproductive Health, New Therapeutic Areas and/or Europe - Jan Honoré
Senior Director, Global Business Development
Phone +41 58 301 00 00 (Switzerland)
Email: Jan.Honore@ferring.com
